SILICON VALLEY, Calif.--(BUSINESS WIRE)--Aug 5, 2026--
Archer Aviation Inc. (NYSE: ACHR) today announced its aviation foundation model, ZEE, achieved a technical breakthrough demonstrating the capability to accurately predict real-time aircraft trajectories on the airport surface minutes into the future, a frontier breakthrough in its mission to lead the industry in building physical AI for aerospace and defense. Archer shared the technical details underpinning this achievement in a technical blog, also released today.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805523533/en/
Controllers and flight crews face the growing cognitive burden of coordinating over 44,000 daily flights across the National Airspace System. While most modernization efforts focus on airspace congestion, runway-related incidents account for 30% to 40% of global aviation accidents. As demand on the National Airspace System continues to grow, modernization requires AI systems that can process complex airspace data in real time, extending the situational awareness of pilots and controllers.
Archer's goal with ZEE is to move beyond passive data aggregation, establishing it as an active, highly accurate predictive layer for air traffic management around the world, creating a proactive, safer, more scalable foundation for the next era of aviation.
“ZEE provides a highly accurate ‘window into the future,’ transforming raw observations from a myriad of inputs into predictive context, helping to identify path anomalies and cross-route conflicts before they develop into safety risks. We believe ZEE can give the humans in the loop the most critical asset in aviation: time to react,” said Mario Srouji, VP of AI Products at Archer.
Prediction models struggle with the fluid, branching choices an aircraft can make on the ground. To solve this, ZEE was purpose-built by Archer’s leading AI team using a state-of-the-art generative framework called “conditional flow matching” to model the full distribution of possible futures rather than a single rigid path. This capability is paired with a vision transformer trained on high-resolution satellite imagery, enabling ZEE to "see" native map features like runways, taxiways, and aprons, grounding its spatial calculations and predictions in real-world physical data.
Archer has already begun testing this technology at Hawthorne Airport, which Archer acquired control of late last year. Early results measured against real-world tracking data have been strong, and larger-scale testing is now underway.
To safely transition this technology into the aviation ecosystem, Archer will work with government agencies to build the rigorous empirical foundation needed to further demonstrate ZEE’s effectiveness as a predictive safety net supporting human controllers and pilots across the globe.
About Archer
Archer builds the aircraft and core technologies that will define the next era of flight for aerospace and defense.
Source: Archer
Text: ArcherIR
Forward-Looking Statements and Disclaimers
This press release contains forward-looking statements regarding Archer’s future business plans, expectations, and opportunities. These statements include those regarding design, target specifications and use cases of its technologies; timing of Archer’s development and commercialization of its technologies; development of its planned lines of business and opportunities; and anticipated benefits of collaborations with third parties. Forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors. The risks and uncertainties that could cause actual results to differ from the results predicted are more fully detailed in Archer’s filings made with the Securities and Exchange Commission from time to time, available at investors.archer.com and at www.sec.gov. Any forward-looking statements contained herein are based on assumptions that Archer believes to be reasonable as of the date of this press release. Archer undertakes no obligation to update these statements as a result of new information or future events.
Image depicts airport surface trajectories prediction by Archer’s ZEE
SAN DIEGO--(BUSINESS WIRE)--Aug 5, 2026--
As pharmacies expand their role in immunizations, preventive care, specialty medication therapies, and other clinical services, they are encountering new opportunities to improve patient access — and greater complexity in billing and reimbursement, particularly for services and therapies covered under the medical benefit. At NACDS Total Store Expo (booth #1823), XiFin, Inc., a leader in AI-driven revenue cycle management (RCM), will showcase XiFin Empower CareALERTS®, Empower RCM, Empower AI, and the new Empower AI Appeals Agent, demonstrating how pharmacies can strengthen patient engagement, improve reimbursement performance, and scale clinical services more sustainably.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805789964/en/
This transformation is poised to accelerate as federal policymakers work to enact legislation such as the Main Street Pharmacy Access Act, which would expand opportunities for pharmacists to provide and receive reimbursement for covered clinical services. In addition, specialty pharmacies in particular face growing medical billing and reimbursement complexity, as many specialty therapies and related services are covered under medical rather than pharmacy benefits. Together, these developments are increasing the need for sophisticated medical billing, revenue cycle management, and appeals capabilities.
The upcoming vaccination season illustrates one immediate opportunity for pharmacies to expand their impact. According to XiFin’s 2026 Pharmacy Transformation Outlook Survey, 98% reported offering immunizations, making vaccinations the most widely delivered clinical service among participating pharmacies. Immunizations also ranked among the strongest-performing clinical services from a reimbursement perspective.
To help pharmacies identify and engage eligible patients while addressing these growing reimbursement challenges, XiFin will showcase XiFin Empower CareALERTS. The solution uses prescription and state immunization registry data to identify care opportunities and deliver actionable smart clinical messaging within pharmacy workflows. By helping pharmacists proactively engage patients who may be eligible for recommended vaccinations based on CDC and ACIP guidelines, CareALERTS supports efforts to close immunization gaps, improve access to preventive care, and strengthen community health outcomes. In 2025, CareALERTS technology successfully increased companion immunizations by 17% among participating pharmacies, while increasing operational efficiency and freeing up pharmacists to deliver more patient care.
“The impact on our patients and our team members was immediate. The solution eliminated 1.7 million workflow vaccination tasks, dramatically improving our operational efficiency and freeing up valuable staff time,” said Whitney DuBois, Systems Manager of Data Operations at Kroger. “These early results have exceeded our expectations,” she added.
Beyond immunizations, the continued expansion of pharmacy-based clinical services and specialty pharmacy is increasing pharmacies’ exposure to medical billing requirements, complex coverage policies, documentation demands, denials, and appeals. XiFin Empower RCM for Pharmacy and Empower AI help organizations manage these workflows across the revenue cycle, while the new Empower AI Appeals Agent addresses one of the most labor-intensive components of revenue management.
The Appeals Agent evaluates payor requirements, analyzes supporting documentation, identifies applicable coverage criteria, assembles supporting evidence, and generates customized appeal packages and submits them to payors. By automating complex appeals workflows, the Empower AI Appeals Agent helps pharmacies reduce manual effort, improve operational efficiency, accelerate revenue recovery, and manage the growing reimbursement complexity associated with medical benefit services and specialty drug therapies.
The Empower AI Appeals Agent is part of XiFin’s broader Empower AI ecosystem, which helps streamline administrative tasks, improve reimbursement accuracy, prioritize work based on financial impact, reduce manual touches, and enable pharmacies to scale clinical services more efficiently while navigating increasingly complex payor requirements.
“Pharmacies are entering one of the most exciting periods of transformation in the industry’s history,” said David Pope, PharmD, Chief Pharmacy Officer at XiFin. “As pharmacists take on a larger role in delivering vaccinations, preventive services, and other clinical care, they have an opportunity to improve health outcomes for more patients than ever before. XiFin Empower solutions are designed to help pharmacies confidently seize that opportunity — connecting more patients to care, simplifying reimbursement complexity, improving operational efficiency, and supporting long-term financial sustainability.”
Visitors to booth #1823 at NACDS Total Store Expo can learn more about how CareALERTS works within pharmacists’ existing workflows to highlight vaccination opportunities and see live demonstrations of Empower AI Appeals Agent. To learn more or to schedule a meeting with XiFin during NACDS TSE, visit the XiFin event page.
About XiFin
XiFin is a healthcare information technology company that empowers organizations to navigate an evolving and increasingly complex healthcare landscape. The XiFin Empower AI RCM ecosystem and trusted data employ active intelligence and automation to reduce manual touches, coordinate workflows, accelerate customer innovation, and improve financial outcomes. Our comprehensive set of solutions — spanning revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement — deliver The Power to Do Good ® so that healthcare organizations can do more good for more patients. Visit www.XiFin.com, follow XiFin on LinkedIn, or subscribe to the XiFin blog to learn more.
XiFin Empower: Advancing Patient Engagement, Clinical Services, and Financial Performance
